Dalhousie University

Synaptive Medical Inc. Awarded Inaugural INOVAIT Focus Fund Investments to Fund MRI Project

Retrieved on: 
Monday, March 6, 2023
Strategic Innovation Fund, Diagnosis, Artificial intelligence, Sunnybrook Research Institute, Neoplasm, Local government in Canada, MRI, Dalhousie University, Research and development, Investment, Stroke, Neurology, AI, ENT, Pharmaceutical industry, Medical imaging, Research

The Focus Fund investments will support commercialization-focused research and development projects for Canadian technology companies at the intersection of advancing imaging, minimally invasive surgery, and artificial intelligence.

Key Points: 
  • The Focus Fund investments will support commercialization-focused research and development projects for Canadian technology companies at the intersection of advancing imaging, minimally invasive surgery, and artificial intelligence.
  • “We are very excited to be participating in such a forward looking and timely initiative,” said Cameron Piron, Co-founder, and President at Synaptive Medical.
  • “It is an honour to have been selected for investment from INOVAIT,” said Alex Panther, Director of Research and Development at Synaptive Medical.
  • Funding for this project was provided in part by INOVAIT through the Government of Canada's Strategic Innovation Fund.

Breaking barriers, empowering communities, mobilizing change: Meet the 2023 Top 25 Women of Influence® recipients

Retrieved on: 
Tuesday, March 7, 2023
Woman, Parity, Life, Participation, Workplace, Social change, Influence, Canada Dry, Entrepreneurship, Partnership, Dalhousie University, Tennis, Black Nova Scotians, 39th Nova Scotia general election, Senior, New Zealand Women of Influence Awards, Nursing, Entertainment

Recipients will be honoured during the Top 25 Women of Influence Luncheon on April 4, 2023, in Toronto.

Key Points: 
  • Recipients will be honoured during the Top 25 Women of Influence Luncheon on April 4, 2023, in Toronto.
  • The Top 25 Women of Influence Awards celebrate women who have made significant contributions to their respective fields.
  • "We are thrilled to be honouring and celebrating the remarkable work of this year's recipients," said Dr. Rumeet Billan, CEO, Women of Influence+.
  • This year's Top 25 Women of Influence Lifetime Achievement Award recipient is Senator Dr. Wanda Thomas Bernard.

ZwitterCo Announces Christopher Ling as Chief Financial Officer

Retrieved on: 
Tuesday, March 7, 2023
University of Virginia Darden School of Business, Membrane, Boston Consulting Group, Robotics, Meat, Commerce, News, Agilent Technologies, CCL Industries, Business administration, Growth, Face, Business, Dalhousie University, Water, Heel, FTI Consulting, University, Veo, Master of Business Administration, CFO, KPMG, Avery Dennison, Sewage treatment, Management

BOSTON, March 7, 2023 /PRNewswire/ -- ZwitterCo, the advanced membrane technology company, today announced the appointment of Christopher Ling as Chief Financial Officer. He brings more than 25 years of financial leadership and a proven track record of successfully leading companies through accelerated product development and growth.

Key Points: 
  • BOSTON, March 7, 2023 /PRNewswire/ -- ZwitterCo , the advanced membrane technology company, today announced the appointment of Christopher Ling as Chief Financial Officer.
  • Ling's expertise in scaling companies is ideal as ZwitterCo is expanding into new markets to meet demand.
  • "Christopher is a financial executive with a breadth of experience that will enable ZwitterCo's next phase of company growth," said Alex Rappaport, co-founder and CEO of ZwitterCo.
  • Most recently, Ling served as Chief Financial Officer for Veo Robotics, Inc., where he led finance, operations, IT and other support functions across the company.

Minister Rodriguez announces the appointment of Dr. Karen Dodds as the new Chairperson of the Canadian Museum of Nature's Board of Trustees

Retrieved on: 
Tuesday, February 21, 2023
Organization, SSHRC, Environment, Intergovernmental Panel on Climate Change, Natural science, Global Outbreak Alert and Response Network, Trustee, Inclusion, University, Dalhousie University, CIHR, Assistant, Natural history, World Health Organization, Bachelor, Microbiology, Climate change, Health Canada, Museum Act (Japan), Committee, Diversity, Environment and Climate Change Canada, The Act, Engineering, Museum, Research, Health, Official Committee of Equity Security Holders, Policy, Canadian Museum of Nature, Knowledge, NSERC, Education, Chairperson, The, Chair, Nursing, Tourism, Nature, QC, Science

From 2011 to 2016, she served as Assistant Deputy Minister at Environment and Climate Change Canada.

Key Points: 
  • From 2011 to 2016, she served as Assistant Deputy Minister at Environment and Climate Change Canada.
  • Prior to that, she was Assistant Deputy Minister at Health Canada from 2008 to 2011.
  • The Canadian Museum of Nature is a national museum in the Canadian Heritage Portfolio.
  • "Dr. Karen Dodds is a welcome addition to the Canadian Museum of Nature as Chair of the Board of Trustees.

EnPlusOne Biosciences Expands Scientific Advisory Board

Retrieved on: 
Wednesday, February 8, 2023
Science, Other Science, Biotechnology, Research, Pharmaceutical, General Health, Health, Genetics, Gene editing, Middle States Commission on Higher Education, Wyss Institute, Defence Scientific Advisory Council, MIT, ALS, Young, Therapy, Dalhousie University, Harvard University, Harvard–MIT Program in Health Sciences and Technology, Biochemistry, Editorial, McGill University, Nucleic acid, Angel Award, RNA, George Church, United States Air Force Scientific Advisory Board, Harvard Medical School, Engineering, University, Wyss Institute for Biologically Inspired Engineering, Nucleic Acids Research, Oligonucleotide, Gene silencing, Outline of health sciences, Knowledge, OTS, Disease, Bachelor of Science, University of Massachusetts Chan Medical School, Angel, University of Massachusetts, Enzyme, Wyss, Doctor of Philosophy, Fine chemical, Management, Chemistry

EnPlusOne Biosciences, Inc. , a biotechnology company harnessing the power of enzymes to synthesize RNA oligonucleotides, today announced that Jonathan K. Watts, Ph.D., Professor, RNA Therapeutics Institute and Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Chan Medical School, has been appointed to the company’s Scientific Advisory Board.

Key Points: 
  • EnPlusOne Biosciences, Inc. , a biotechnology company harnessing the power of enzymes to synthesize RNA oligonucleotides, today announced that Jonathan K. Watts, Ph.D., Professor, RNA Therapeutics Institute and Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Chan Medical School, has been appointed to the company’s Scientific Advisory Board.
  • Dr. Watts, who was also a member of the Board of Directors of the Oligonucleotide Therapeutics Society (OTS) from 2015 to 2021, is a highly regarded scientific investigator in the oligonucleotide field.
  • Daniel Wiegand, MSChE, CEO of EnPlusOne said, “We are delighted to attract an experienced, respected researcher like Jon to our Scientific Advisory Board.
  • He serves on the Editorial Boards of Nucleic Acid Therapeutics and Nucleic Acids Research in addition to the Scientific Advisory Council of the OTS.

RION Announces the Advisory Appointments of John Ballantyne, Ph.D., to Chair of the Rion Scientific Advisory Board and Andrew D. Badley, M.D., to Chair of the Rion Medical Advisory Board

Retrieved on: 
Wednesday, January 25, 2023
Biotechnology, Cosmetics, Retail, Health, Manufacturing, Pharmaceutical, Research, Other Retail, General Health, Fitness & Nutrition, Science, Other Manufacturing, Clinical Trials, Medical Supplies, North Dakota State University, Vaccine, Collection, Physician, GMP, Government, Mayo Clinic, SARS-CoV-2, Central Institute of Technology, Kokrajhar, Danaher, Therapy, Dalhousie University, Central Institute for Experimental Animals, Autumn, Development, Retirement, The Co Founder, Rion, University, Division, Cardiology, CSO, Entrepreneurship, Infection, United States Air Force Scientific Advisory Board, HIV, DRS, Exosome, Immune system, Wound healing, Molecular medicine, Ballantyne, COVID-19, Badley, Medical device, Pharmacy

RION, a clinical-stage regenerative medicine company with breakthrough platform technology leveraging platelet-derived exosomes, announces the appointment of Dr. Ballantyne as Chair of the company’s Scientific Advisory Board and Dr. Andrew D. Badley as Chair of the Rion Medical Advisory Board.

Key Points: 
  • RION, a clinical-stage regenerative medicine company with breakthrough platform technology leveraging platelet-derived exosomes, announces the appointment of Dr. Ballantyne as Chair of the company’s Scientific Advisory Board and Dr. Andrew D. Badley as Chair of the Rion Medical Advisory Board.
  • “We are honored to have Dr. Ballantyne and Dr. Badley as a part of the Rion team,” said Dr. Atta Behfar, Rion CEO and Co-Founder.
  • Dr. Ballantyne holds undergraduate degrees in Pharmacy from the Central Institute of Technology and the University of Otago in New Zealand.
  • “Dr.

IFIC Names Andy Mitchell as its New President and CEO

Retrieved on: 
Thursday, January 5, 2023
Business administration, Mitchell, Bank, Standard Life (Canada), SEI, Dalhousie University, Investment, Human, Management

TORONTO, Jan. 05, 2023 (GLOBE NEWSWIRE) -- The Investment Funds Institute of Canada (IFIC) today announced that Andrew “Andy” Mitchell has been named the organization’s new President and CEO, following an extensive national search.

Key Points: 
  • TORONTO, Jan. 05, 2023 (GLOBE NEWSWIRE) -- The Investment Funds Institute of Canada (IFIC) today announced that Andrew “Andy” Mitchell has been named the organization’s new President and CEO, following an extensive national search.
  • Mr. Mitchell will also become President and Board Chair of the IFSE Institute, IFIC’s wholly-owned financial services education arm.
  • “I am very proud and honoured to have been selected to lead IFIC,” said Mr. Mitchell.
  • “IFIC benefitted immensely from Paul’s expertise and his stellar reputation for being an honest, collegial and reasonable voice for our industry and the investors we serve.”

Bitfarms Promotes Geoffrey Morphy to Chief Executive Officer

Retrieved on: 
Thursday, December 29, 2022
Bitcoin, Corporate development, Institute of Corporate Directors, TSX Venture Exchange, Administration, Executive, TSX, News, Growth, Accreditation, Farm, Dalhousie University, Commerce, Bachelor of Commerce, REIT, Management, Cryptocurrency

TORONTO, Ontario and BROSSARD, Québec, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (NASDAQ: BITF // TSX: BITF), a global Bitcoin self-mining company, promoted President and Chief Operating Officer Geoffrey Morphy to the position of President and Chief Executive Officer effective immediately.

Key Points: 
  • TORONTO, Ontario and BROSSARD, Québec, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (NASDAQ: BITF // TSX: BITF), a global Bitcoin self-mining company, promoted President and Chief Operating Officer Geoffrey Morphy to the position of President and Chief Executive Officer effective immediately.
  • Co-founder Nicolas Bonta will shift from the position of Executive Chairman to the role of Chairman of the Board of Directors.
  • “At the time I joined, Bitfarms was already one of the largest Bitcoin producers with strong operators and uniquely positioned for growth.
  • The opportunity to capitalize on this solid foundation to build something great and long-lasting was undeniable,” said Mr. Morphy.

STEMCELL Technologies President and CEO Dr. Allen Eaves Appointed to the Order of Canada

Retrieved on: 
Thursday, December 29, 2022
Research, Public Policy, Government, Stem Cells, Biotechnology, Other Health, White House, Federal Government, Health, General Health, Science, BC Cancer Agency, Mentorship, Friends, Research, Hope, University, Multimedia, Stemcell Technologies, Science, Acadia University, Biology, Development, Vancouver General Hospital, Research and development, Heart, Internal medicine, Dalhousie University, Oncology, Order, The Right Honourable, Senior, Hospital, Doctor of Philosophy, Management, Medical device

STEMCELL Technologies President and CEO Dr. Allen Eaves has been appointed to the Order of Canada -- one of the nation’s highest forms of recognition. (Photo: Business Wire)

Key Points: 
  • STEMCELL Technologies is proud to announce its President and CEO, Dr. Allen Eaves, has been appointed to the Order of Canada by Her Excellency the Right Honourable Mary Simon, the Governor General of Canada.
  • View the full release here: https://www.businesswire.com/news/home/20221229005015/en/
    STEMCELL Technologies President and CEO Dr. Allen Eaves has been appointed to the Order of Canada -- one of the nation’s highest forms of recognition.
  • (Photo: Business Wire)
    One of the nation’s highest forms of recognition, the Order of Canada recognizes people who make extraordinary contributions to Canadian society.
  • “Being appointed to the Order of Canada is an honour of a lifetime, and I am grateful for the countless colleagues, mentors, friends, and family members who supported me throughout my career,” Dr. Eaves said.

Monitoring surface waters from space to help address impacts of climate change

Retrieved on: 
Friday, December 16, 2022
Water, SpaceX launch vehicles, Estuary, Vandenberg Space Force Base, Lake, McGill University, Drought, CPI, Sherbrooke, Weather, SpaceX, SWOT, Water resources, Science, Environment and Climate Change Canada, Wilfrid Laurier University, Fishery, UK Space Agency, University of Toronto, Canadian Space Agency, CNES, Dalhousie University, Eike-Henner Kluge, NASA, Environmental monitoring, Environment, University, CSA, River, Communication, Climate change, Communications satellite, Aquaculture, QC

It will provide scientists with precise water level measurements on oceans and inland water bodies to help address the impacts of climate change and improve water management.

Key Points: 
  • It will provide scientists with precise water level measurements on oceans and inland water bodies to help address the impacts of climate change and improve water management.
  • SWOT is an international mission led by NASA and France's space agency, CNES (Centre national d'tudes spatiales), with contributions from the Canadian Space Agency (CSA) and the UK Space Agency.
  • Using SWOT data, Canadian researchers will tackle pressing climate issues such as availability of freshwater resources and our changing oceans, coasts and inland waters.
  • This mission will provide Canadian scientists with valuable data to help understand our oceans, vast coastlines, and how climate change affects our waters."